http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100368072-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-48 |
| filingDate | 1999-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100368072-B1 |
| abstract | PURPOSE: A lignan compound saururin A having antioxidant activity for lipoproteins having low density is provided, thereby the lignan compound can be used for the prevention and treatment of circulatory diseases including arteriosclerosis. CONSTITUTION: The lignan compound saururin A having antioxidant activity for lipoproteins having low density is represented by formula (1). The lignan compound saururin A is produced by the following steps of: extracting the powder of Saururus chinensis Baill roots with methanol; extracting the first extract with water, n-hexane and chloroform; separating the second extract by developing it on silica gel column chromatography using n-hexane and ethyl acetate mixed solvent as developing solvents; separating the eluate by developing it on reverse phase silica gel column chromatography using methanol as a developing solvent; and separating the eluate by developing it on silica gel column chromatography using chloroform and methanol mixed solvent as developing solvents. |
| priorityDate | 1999-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.